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Medical consequences of acute 
exposure to high altitude 
Carl P. Hallenborg MD 
People who ascend rapidly to altitudes greater than 3,000 
meters (JO,OOOft) may become ill; rarely, some may die from 
an inability to adapt to hypoxia. Age, pre-existing cardiopul-
monary or hematologic disease, and the rate and degree of 
ascent are known to limit man's adaptation to high altitudes. 
Other factors, such as blunted hypoxic respiratory drive and 
sublinical disease of the pulmonary vascular bed are probably 
also important. Pre-exposure with acetazolamide (Diamox) 
helps, but once symptoms of high altitude pulmonary edema 
(HAPE) occur, supplemental oxygen and rapid descent to 
lower altitudes are the only known remedies. In view of the 
steady increase in the number of people who work and play at 
high altitudes, physicians must understand the pathophysio-
logic mechanisms involved in order to treat properly and to 
counsel patients. 
Exposure to altitudes over 3,000 meters rapidly or sudden-
ly is known to cause many people discomfort, and it can sub-
ject a few to life-threatening disease. Although objective data 
are scarce because of logistical problems, many people com-
plain of lassitude and headache; few will have frank pul-
monary congestion and will collapse1.2. Now that transporta-
tion to high altitudes has improved, and interest in work and 
play at high altitudes has increased, one may anticipate that 
more people will be at risk. Mountain-climbing and skiing are 
popular sports. They frequently take place at altitudes over 
3,000 meters. Astronomers frequently work at 5,000 meters 
and above. Border conflicts resulting in military operations 
can involve thousands of people at high altitudes. Most of the 
illnesses and devastating consequences of high altitude expo-
sure are avoidable. 
Physiologic mechanisms 
Although our knowledge of the mechanism is incomplete, 
hypoxia, of all of the physical factors involved, is the most 
important. As one ascends, barometric pressure and partial 
pressure of oxygen (PaCh) fall, so that at 3,000 meters only 
100 mm torr (torr = 1/760 of 1 atmosphere) of oxygen is 
available at one's mouth (Fig. 1). Even less is available to the 
cells of the body because of the oxygen cascade (Fig. 2), the 
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precise PaCh varies according to individual differences in ven-
tilation, diffusion, and the ventilation-to-perfusion balance. 
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FIGURE 1: Relationship between altitude and concentration 
of inspired oxygen. 
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FIGURE 2: In the healthy subject, as one ascends (not 
shown) available oxygen is diminished and body tissues 
become more dependent on cardiopulmonary and hemato-
logic mechanisms to supply adequate oxygen to tissues. 
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FIGURE 3: Basic adaptive mechanisms for acute high alti-
tude exposure and cause of illnesses commonly seen at 
high altitude. 
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2,000 
2-3,000 
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Disease 
(% incidence) 
hypoxemia 
(frequent 
generalized (5) 
edema 
thromboplebitis 
(rare) 
acute mtn (50) 
sickness 
high altitude 
pulm edema (1) 
retinal 
hemorrhage (1) 
cerebral (1) 
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Common Treatment 
Symptoms (* required) 
dyspnea slow ascent 
Chprn 
swelling mild diuresis 
painful leg *descent for 
swelling treatment 
headache pretreatment 
nausea Diamox 
fatigue ASA 
dyspnea *(), 
cough *descent 
congestion 
blind spots descent 
severe *(), 
headaches *descent 
hallucinations steroids? 
neurologic 
deficits 
coma 
FIGURE 4: Life threatening illness rarely occurs in the 
healthy subject below 3,000 meters. *When such occurs, 
descent and supplemental oxygen are the only known treat-
ments. 
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Since these measurements are not very commonly done at rest 
or during exercise one can expect and find a considerable vari-
ation in a person's adaptation to hypoxia. Besides this, hypox-
ia triggers a marked response by and in the bodyl·4 (Fig. 3). 
The "hypoxic drive" causes hyperventilation (fortunately 
for most, the decreased density of air reduces the effort need-
ed to respire). This does not completely obviate hypoxemia; it 
routinely causes respiratory alkalosis. Hypoxemia results in 
pulmonary artery vasoconstriction and hypertension. Alkalo-
sis causes an increased production of 2,3-diphosphoglycerate 
(DPG). With an understanding of these basic facts, we are 
able to speculate on the mechanisms involved in the disorders 
usually seen at high altitude. 
High altitude illnesses 
As expected, symptoms and disease are related to the stress 
(precipated by high altitude in relation to underlying condi-
tions). In fact, serious illness does not occur at 2,000 meters. 
Everyone is affected at> 3,000 meters because of hypoxemia, 
but it is a failure in the adaptive mechanism, or the presence 
of an underlying medical condition, that may result in a seri-
ous disorder and, rarely, a life-threatening situation. 
Diseases affecting 
"healthy" subject 
1. Acute mountain illness. This is more uncomfortable 
than serious. Headache, nausea, weakness and shortness of 
breath are the usual symptoms which occur after rapid ascent 
to altitudes above 7,000 feet, and disappear after 1 to 2 days at 
that altitude. The suggested causative mechanism is hypox-
emia with mild cerebral edema. This can be alleviated by pro-
phylactic treatment with acetazolamide or by slow ascent. 
2. High altitude cerebral edema and encephalopathy. In 
those who trek above 14,000 feet, a more severe dysfunction 
of the central nervous system occurs, though rarely, with hal-
lucinations, sleepiness, symmetrical neurologic deficits and 
sometimes coma. Immediate descent, oxygen and perhaps 
steroids are indicated to prevent permanent neurologic deficits 
or death. 
3. High altitude retinal hemorrhages. Small hemorrhages 
commonly occur and may temporarily affect vision, especially 
if they involve the macula. However, descent clears the hem-
orrhages and vision returns to normal. 
4. High altitude pulmonary edema. The most common, 
severe, and potentially life-threatening disease that happens 
with moderate high altitude exposure is high altitude pul-
monary edema (HAPE). HAPE affects young "healthy" sub-
jects at above 3,000 meters and unless treated promptly and 
effectively may lead to death. The victim experiences chest 
pain, dyspnea and cough; this may rapidly lead to frank pul-
monary edema. Supplemental oxygen must be given and the 
patient transported immediately to lower altitudes. The usual 
methods of treatment of pulmonary edema such as morphine, 
diuretics and digitalis are not efficacious and may complicate 
the picture by causing postural hypertension and shock. A 
slow ascent may be preventative, but premedication has no 
proven worth. 
5. Generalized edema. Massive generalized edema may 
(Continued) .... 
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occur in some people even at low altitudes and may respond 
to diuretics. Thrombophlebitis and pulmonary embolism are-
more likely to occur if treatment is not instituted promptly 
(Fig. 4). 
In the healthy subject, diseases associated with high alti-
tude exposure, though varied in expression, seem to have in 
common abnormal retention of water in tissues damaged by 
hypoxia, or because of inadequate "normal" mechanisms. To 
be on the safe side, oxygen should be given and descent 
advised. For the individual whose judgment seems to be 
clouded by hypoxia, this is always the prudent course. In a 
group that is experienced and has good judgment, symptomat-
ic treatment for benign conditions is a satisfactory alternative. 
High altitude exposure in 
patients with medical problems 
In patients with diseases that are extremely sensitive to 
hypoxia, or whose adaptive mechanisms are poor, even mod-
erate high-altitudes (~ 3,000 meters) may cause problems. 
1. Altered hypoxic response. In persons who do not adjust 
readily to hypoxia or who have blunted respiratory drives to 
alkalemia, high altitude may be dangerous. These are usually 
persons with disease-causing C02 retention even at sea level. 
2. Patients in whom hypoxemia cannot be tolerated. 
Coronary artery disease, cerebral vascular insufficiency, sickle 
cell disease and severe anemia are obviously conditions that 
preclude exposure to high altitude. 
3. Persons who cannot increase ventilation sufficiently. 
It seems paradoxical that many patients with chronic bronchi-
tis and asthma do surprisingly well at high altitude. It is well-
known that patients with obstructive lung disease may have 
obstruction in small or in large airways (or in some combina-
tion thereof). If obstruction is in the small airways, the 
decreased density of air at high altitudes offers no ease to the 
movement of air; these patients do badly. If obstruction is in 
the large airways, however, the rarefied air may actually be 
beneficial. No study has been reported (nor would it be entire-
ly ethical) to test this hypothesis. 
4. Restriction of the pulmonary capillary bed. HAPE 
occurs with alarming frequency in people with congenital 
absence of a main pulmonary artery6 and since the mechanism 
appears to be one of pre-capillary edema, these persons with 
mild to moderate loss of cross-sectional area of the capillary 
bed might be at greater risk. Patients with emphysema, pul-
monary resection, or interstitial lung disease are at great risk 
and exposure to high altitudes should be discouraged. If 
HAPE can occur even in the "healthy", it is a given that 
patients with these disorders should be totally excluded. 
The patient on cardiopulmonary medications likewise 
should also be discouraged from going to high altitudes 
because the effectiveness of these medications may be vari-
able. 
The use of drugs 
Medications should be used sparingly and by those knowl-
edgeable in the physiologic consequences and adaptations to 
high-altitude exposure. 
1. Oxygen. Oxygen should always be available and used 
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freely if there is any doubt about what occurs. Lightweight, 
efficient, oxygen containers are available and easy to use. 
2. Diuretics. Despite the relatively frequent symptoms and 
signs of excess fluid, these medications should be used with 
great care. The edema is usually extravascular so that a rapid 
diuresis may compound a difficult situation already begun. 
Acetozolamide is beneficial by preventing a blunted hypoxic 
drive and so should be used both before and during the ascent. 
Other respiratory stimulants, such as progesterone, have 
some theoretical appeal but their side effects of fluid retention 
make them of lesser or of no value. A mild respiratory stimu-
lant such as theophylline may be useful but, to my knowledge, 
it has not been properly evaluated. 
3. Hypnotics and sedatives. Despite the frequent symp-
toms of muscle cramps, headache and sleeplessness, hypnotics 
and sedatives (including alcohol) because of their effect on 
respiratory drive and judgment should never be used. 
4. Tobacco. Inadvertent inhalation of carbon monoxide ties 
up badly needed hemoglobin and should be strictly avoided 
(Fig. 5). 
General advice to the person who plans to ascend rapidly 
includes the following: 
a. If you have known cardiopulmonary disease avoid 
exceeding 2,000 meters. 
b. If you are a healthy traveler who plans an ascent over 
3,000 meters, you should take acetozolamide 250 mg tid 
the day before and the day of ascent. 
c. You should know the signs and symptoms of benign 
and significant high altitude illnesses and how to treat 
them. 
d. Oxygen and a planned route for rapid descent should 
always be available and taken if there is any suspicion of 
significant illness. 
e. The use of tobacco, alcohol, sedatives and hypnotics 
is strictly forbidden. 
f. If you plan to work at high altitudes, you should have 
a thorough medical evaluation that includes a history, 
Drugs Effect Usefulness 
02 relieves hypoxemia dyspnea, HAPE, 
cerebral edema 
diuretics 
1) Diamox causes acidosis pretreatment AMA 
increases hypoxic drive 
2) Lasix® diuresis generalized edema 
not HAPE 
hypotics, decreases drive never 
sedatives, impairs concentration 
alcohol 
tobacco binds Hgb never 
FIGURE 5: Pretreatment with Diamox and supplemental 
oxygen are the only medications proved useful at high alti-
tude. 
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physical examination, complete blood count, chest roent-
genogram and possibly exercise pulmonary function testing 
for hypoxic and hypercapneic drives. 
g. Because of possible effects of hypoxemia on the 
fetus, if you are pregnant you should not ascend above 
3,000 meters. 
h. If you become ill at modest altitudes, a complete 
appraisal should be done at that point and further exposure 
to higher altitudes limited. 
Conclusion 
Rapid exposure to moderate (3,000 meters) and high (5,000 
meters) altitudes is uncomfortable for most people and life-
threatening for some. With a knowledge of the physiologic 
principles of adaptation to high altitude and understanding of 
the signs and symptoms of diseases associated with such 
exposure, the physician and the traveler will be able to prevent 
both serious illness and death. 
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State of Hawaii. In order to achieve these key health objec-
tives, a large number of occupational-health professionals will 
be needed. The University of Hawaii School of Public Health 
expects to play an important role in their training. 
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dence of 1 in 1,000, a study population of 10,000 is required. BffiUOGRAPHY 
The risk of having any cancer per year is 3-4 per 1,000 popu-
lation. The incidence of having a particular cancer is much 
lower and the study group required must be much larger. 
Other criteria for causality have to be considered, especial-
ly biologic plausibility. Toxicologic data from studies of cell 
cultures or in animals often supply information which cannot 
be duplicated in human studies because it is impossible to 
expose the latter to experimental doses of toxic agents. Cau-
tion is advised, therefore, when so-called plausibility is used 
as a substitute for detailed information. 
What seems "reasonable" in regards to causality is not nec-
essarily true. Even though environmental epidemiology has 
made very valuable contributions to our knowledge of envi-
ronmental hazards, the results reported in every study should 
be critically evaluated, keeping in mind the difficulties inher-
ent in their methodology. 
HAwArrMEmcALJOURNAL-VoL. 50, No. 3-MAR.CH 1991 
Center for Environmental Epidemiology, University of Pittsburgh and U.S. 
Environmental Protection Agency. First International Symposium on 
Environmental Epidemiology. Archives of Environmental Health Vol. 
43:69-204, 1988. 
Fox, J.P., Hall, C.E. and L.R. Elveback Epidemiology: Man and Disease. 
Macmillan, New York, 1970. 
Goldsmith, John R. Environmental Epidemiology: Epidemiological Investiga-
tion of Community Environmental Health Problems CRC Press, Boca 
Raton, Florida, 1986. 
Kopfler, Frederick C. and Gunther F. Craun: Environmental Epidemiology. 
Lewis Publishers, Chelsea, Michigan, 1986. 
U.S. Dep. of Health and Human Services. Second Annual Symposium on 
Environmental Epidemiology. Environmental Health Perspectives Vol. 
52:1-160, 1983. 
• 
99 
